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 2
Abstract 28 
Cerebral circulation is secured by feed-forward and feed-back control pathways to maintain 29 
and eventually reestablish the optimal oxygen and nutrient supply of neurons in case of 30 
disturbances of the cardiovascular system. Using the high temporal and spatial resolution of 31 
laser-speckle imaging we aimed to analyze the pattern of cerebrocortical blood flow (CoBF) 32 
changes after unilateral (left) carotid artery occlusion (CAO) in anesthetized mice in order to 33 
evaluate the contribution of macrovascular (circle of Willis) vs. pial collateral vessels as well 34 
as that of endothelial nitric oxide synthase (eNOS) to the cerebrovascular adaptation to CAO. 35 
In wild-type mice CoBF reduction in the left temporal cortex started immediately after CAO, 36 
reaching its maximum (-26%) at 5-10 s. Thereafter, CoBF recovered close to the pre-37 
occlusion level within 30 s indicating the activation of feed-back pathway(s). Interestingly, 38 
the frontoparietal cerebrocortical regions also showed CoBF reduction in the left (-17-19%) 39 
but not in the right hemisphere, although these brain areas receive their blood supply from the 40 
common azygos anterior cerebral artery in mice. In eNOS-deficient animals the acute CoBF 41 
reduction after CAO was unaltered, and the recovery was even accelerated as compared to 42 
controls. These results indicate that (i) the Willis circle alone is not sufficient to provide an 43 
immediate compensation for the loss of one carotid artery, (ii) pial collaterals attenuate the 44 
ischemia of the temporal cortex ipsilateral to CAO at the expense of the blood supply of the 45 
frontoparietal region, and (iii) eNOS, surprisingly, does not play an important role in this 46 
CoBF redistribution. 47 
 48 
New & Noteworthy 49 
Temporal and spatial pattern of cerebrocortical blood flow changes after unilateral carotid 50 
artery occlusion has been determined by laser-speckle imaging in mice. The main 51 
conclusions are that microvascular feed-back mechanisms involving pial collaterals aid the 52 
Willis circle in the cerebrovascular adaptation, and eNOS, surprisingly, is not important in 53 
this process. 54 
 55 
Keywords: cerebrocortical microcirculation, carotid artery occlusion, cerebrovascular 56 
regulation, pial collateral circulation, eNOS 57 
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Introduction 59 
An important characteristic of cerebral circulation is the remarkable steadiness of the cerebral 60 
blood supply at rest as well as during disturbances of the systemic circulation. In order to 61 
meet the high metabolic demands of neurons, astrocytes and pericytes (approx. 7 mg glucose 62 
/ 100 g grey matter / min), the brain must be supplied continuously by approximately 50 ml / 63 
100g / min arterial blood, carrying 3.5 ml / 100 g / min oxygen on average (45). Under 64 
physiological conditions, despite fluctuations of the systemic mean arterial blood pressure 65 
(MABP) between 60-140 mmHg, changes in the partial pressure of arterial blood gases, and 66 
alterations of global or regional neuronal metabolic activity, the necessary rate of cerebral 67 
blood flow is ensured by metabolic, myogenic, endothelial and neural regulatory mechanisms 68 
(4).  69 
The effectiveness of these control systems, however, is not unlimited. Cerebral ischemia is 70 
among the most common causes of death: it contributes to 87% of all strokes (36), and 71 
approximately 30% of strokes are caused by occlusive diseases of the carotid arteries (20). 72 
The overwhelming majority involve the occlusion of the internal carotid arteries (ICA), but 73 
the occlusion of the common carotid artery (CCA) is also responsible for approximately 0.24-74 
5.0% of stroke cases (1). The pathological mechanisms that can lead to either gradual or 75 
sudden carotid artery occlusion include atherosclerosis, thrombosis superimposed on the 76 
atherosclerotic plaque, and carotid artery dissection. Among these, atherosclerosis (by far the 77 
most common occlusive disease affecting the carotid arteries) may lead to either symptomatic 78 
or asymptomatic carotid artery stenosis. The annual stroke rate was found to be 13% in case 79 
of high-grade stenosis (luminal occlusion over 70%), and 7% in moderate stenosis (luminal 80 
occlusion between 30-69%) (49).  81 
It is surprising that following verified partial or complete carotid artery stenosis no serious 82 
neurological deficits can be demonstrated in the majority of patients (19). After ligation of 83 
the CCA (a method historically used for treating ICA aneurysms), focal neurological deficits 84 
were noted only in a minority of the cases and immediate neurological complications 85 
developed only in 4.2-6.4% of the patients (31, 37). These important observations indicate 86 
that in spite of the closure of one critically important source of the arterial blood supply to the 87 
brain (CCA), yet unknown but very efficient compensatory mechanisms step in to maintain 88 
sufficient blood flow to the neurons and keep them alive without significant clinical signs. 89 
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Theoretically, there are at least three possible compensatory mechanisms which may be 90 
involved in the cerebrovascular adaptation to carotid artery occlusion (CAO). First, 91 
compensation may occur in large intracranial vessels within the circle of Willis, where CAO 92 
induces pressure, flow and resistance changes. This theory is supported by the observations 93 
that in most patients ligation of the CCA results not only in a reduced flow, but also in an 94 
immediate reversal of blood flow in the ICA (i.e. away from the brain) for 1-18 hours, after 95 
which the flow returns to the normal forward direction with a reduced rate of 24-50% as 96 
compared to its pre-occlusion level (55). Interestingly, transgenic mice lacking the anterior 97 
connection between the two sides of the circle of Willis were reported to develop severe 98 
neurological symptoms and died after unilateral ligation of the CCA indicating the major 99 
importance of the intracranial collaterals in the cerebrovascular adaptation to CAO (39). 100 
The second possibility for cerebrovascular adaptation to CAO is based on the theory that 101 
under physiological conditions there is a balance between the extracranial collateral 102 
circulation of the head and neck area and the intracranial collateral circulation (Willis circle) 103 
via occipital, facial and maxillary branches of the external carotid artery (ECA). This balance 104 
and, consequently, the blood flow in the ICA and in the ECA can change significantly under 105 
pathological conditions. The anatomy of the Willis circle varies greatly (27), and in case of 106 
an anatomically inadequate circle of Willis, reversal of the flow in the ECA following CCA 107 
occlusion may serve as an immediate collateral blood supply for the ICA (55).  108 
A third possible mechanism could be the recruitment of pial collateral vessels that form 109 
anastomoses between the terminal cortical branches of the major cerebral arteries (i.e. the 110 
anterior, middle, and posterior cerebral arteries) throughout the surface of the brain. The aim 111 
of the present study was to investigate the potential role of these small pial collateral arteries 112 
in the cerebrovascular adaptation to CCA occlusion, with special emphasis on the role of 113 
endothelial nitric oxide synthase (eNOS), a constitutively expressed enzyme, producing nitric 114 
oxide (NO) in the cerebral circulation. NO is known to play a major role in flow-induced 115 
vasodilation of cerebral vessels, in metabolic control of the cerebral blood flow and in 116 
neurovascular coupling (12, 13, 51). Therefore, the participation and potential role of eNOS 117 
and its product, NO, in cerebrovascular autoregulation following complete occlusion of the 118 
left CCA was also investigated. Laser speckle imaging was used to determine and to compare 119 
regional cerebrocortical blood flow (CoBF) changes following permanent unilateral CCA 120 
occlusion in control wild type (WT) and eNOS-deficient (eNOS-KO) mice. 121 
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Methods 122 
The experiments were performed on WT (n=12) and eNOS-KO (n=11) adult male C57Bl6 123 
mice (body weight 25-35 g) according to the guidelines of the Hungarian Law of Animal 124 
Protection (28/1998). All procedures were approved by the National Scientific Ethical 125 
Committee on Animal Experimentation (PEI/001/2706-13/2014). The mice were anesthetized 126 
with 2% inhaled isoflurane during femoral artery catheterization, and with intraperitoneally 127 
(i.p.) applied ketamine (100 μg / g bw. Calypsol, Richter Gedeon Plc., Budapest, Hungary) 128 
and xylazine (10 μg / g bw. CP-Xylazine, CP-Pharma GmbH, Burgdorf, Germany) 129 
throughout the rest of the experiment. The depth of the anesthesia was frequently tested 130 
during the experiments by checking the plantar nociception or corneal reflex, and additional 131 
anesthetic was administered as necessary. The left femoral artery was cannulated under a 132 
stereomicroscope, and it was used for continuous systemic arterial pressure measurement, 133 
and, at the end of each experiment, the same cannula was used for arterial blood sampling for 134 
determination of blood gas tensions and acid/base parameters. Body temperature was 135 
maintained between 36 and 37 °C throughout the experiment by using a heating pad, 136 
controlled by a rectal probe. 137 
Following femoral artery cannulation and intraperitoneal ketamine/xylazine administration, 138 
the trachea was exposed and the mice were allowed to breathe spontaneously through an 139 
intratracheal cannula. Subsequently, the carotid sheath was gently dissected under 140 
microscopic magnification (with particular care to preserve the intact vagus nerve) and a 141 
ligature with a loose knot was placed around the left CCA. 142 
For the measurement of the CoBF, the head of the mouse was secured in a stereotaxic head 143 
holder, and the skull was exposed by retracting the scalp following a midline incision. The 144 
CoBF was measured by using the laser-speckle imaging method (PeriCam PSI, Perimed AB, 145 
Järfälla, Stockholm, Sweden) in three carefully determined and standardized cortical regions 146 
of interest (ROI): frontal, parietal, and temporal cortices of both hemispheres. The reason for 147 
choosing these specific cerebral regions for CoBF determinations was that each of these 148 
regions is supplied by different cerebral arteries (43). In this way one may more accurately 149 
and reliably assess the CoBF alterations and redistributions throughout the entire surface of 150 
the cerebral hemispheres following unilateral CAO. The ROIs for the CoBF measurements 151 
and the blood supply to these regions are depicted in Figure 1. 152 
 6
Two key factors were taken into consideration in order to select the required ROIs as 153 
accurately as possible: 1) any visible major cerebral arteries, veins and venous sinuses were 154 
excluded from the selected ROIs, 2) the cerebrocortical area that is known to have the highest 155 
density of microvascular anastomoses between the main cerebral arteries was also excluded 156 
from the ROI selection as this area has dual blood supply (28, 29, 50). The localization of the 157 
pial anastomoses between the territories of the middle and anterior cerebral arteries (MCA 158 
and ACA) has been determined by Maeda et al (28, 29). According to these coordinates we 159 
aimed to set the temporal region laterally, whereas the frontal and parietal regions medially 160 
from the zone of anastomoses in order to clearly demarcate the territories supplied by the 161 
MCA and the ACA (Figure 1). (It has to be noted that in mice the two ACA fuse and give 162 
rise to the azygos anterior cerebral artery (AACA) which supplies the frontoparietal cerebral 163 
cortex of both hemispheres (43).) The CoBF of the frontal and parietal regions have been 164 
evaluated separately because the parietal region may receive additional pial collaterals from 165 
the posterior cerebral artery (5), which might improve the capacity of microcirculatory 166 
adaptation in this region. 167 
Prior to starting the CoBF measurements, atipamezole (Sigma-Aldrich Co., St. Louis, MO, 168 
USA; 1 μg/g i.p.) was administered as an antidote to xylazine, to reverse xylazine’s alpha-2 169 
agonistic effects, and in this way to ensure a stable blood pressure throughout the experiment. 170 
Five to ten minutes were allowed for atipamezole’s effect to get established. Following this, 5 171 
to 10 minutes were allowed to acquire baseline data of CoBF and blood pressure. Arterial 172 
blood pressure was measured and recorded continuously during the entire time of the 173 
experiment. 174 
After acquiring the baseline data, the left CCA was occluded by tightening the loose knot 175 
around this vessel. The CoBF parameters, measured by the laser-speckle technique were as 176 
follows: (i) average steady state CoBF value for one minute preceding CAO that was used as 177 
a 100% reference CBF baseline value, (ii) the initial drop of the CBF upon CAO, and (iii) the 178 
dynamics of the CBF changes (“recovery”) following the initial drop of CBF, for 5 minutes 179 
after the CAO. Before terminating an experiment, arterial blood was sampled via the femoral 180 
artery cannula to determine arterial blood gas tensions and acid/base parameters. If arterial O2 181 
saturation was less than 90 % or CO2 tension was out of the range of 25-55 mmHg the 182 
experiment was excluded from the evaluation. Complete occlusion of the CCA has been 183 
verified in each animal by inspection under a stereomicroscope. 184 
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Values in the text, figures and tables are presented as mean ± SEM; n represents the number 185 
of mice tested. Statistical analysis for the arterial blood gas and acid/base parameters was 186 
performed using Student’s unpaired t-test, whereas for the MABP and CoBF two-way 187 
ANOVA with Bonferroni's post hoc test was used. A P value of less than 0.05 was 188 
considered to be statistically significant. 189 
 190 
Results 191 
Systemic physiological parameters 192 
Baseline mean arterial blood pressure (MABP) was stable and within the autoregulatory 193 
range of the cerebral circulation both in WT and in eNOS-KO animals (Figure 2A.). 194 
However, in accordance with reported observations (46, 47), the MABP of eNOS-KO mice 195 
was approximately 25 mmHg higher and more variable as compared to controls. CAO 196 
induced only minor MABP changes in both experimental groups, although the elevation of 197 
the MABP was more pronounced and sustained in mice deficient in eNOS (Figure 2B.). 198 
Importantly, arterial blood gas and acid-base parameters were within the physiological range, 199 
and were not different between WT and eNOS-KO animals (Table 1.). 200 
Effects of CAO on the regional CoBF in WT mice 201 
The first aim of the present study was to analyze the temporal pattern of CAO-induced CoBF 202 
changes in the different cerebrocortical regions in order to answer two questions: (i) does the 203 
adaptation of cerebral circulation to the altered hemodynamic state after CAO involve active 204 
vasodilation, and if so, (ii) do pial collaterals between territories of the main cerebrocortical 205 
arteries (AACA and MCA) contribute to this process? We assumed that analysis of the 206 
temporal pattern of CoBF changes can be used to answer the first question, whereas 207 
development of regional differences within the cerebral cortex can indicate CoBF 208 
redistribution via pial anastomic vessels. 209 
In WT mice CoBF declined rapidly in all three ipsilateral cerebrocortical regions after CAO 210 
(Figures 3, 4A, 4C and 4E). The CoBF reduction was obvious in the temporal cortex within 1 211 
s and reached the maximal level at 5-10 s (Figures 3 and 4E). The CoBF of the frontal and 212 
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parietal regions ipsilateral to CAO decreased simultaneously with that of the temporal cortex 213 
(Figures 4A, 4C and 4E), although their CoBF reduction was significantly less pronounced 214 
(Figure 5A). At approximately 10 s after CAO the CoBF started to increase in all cortical 215 
regions, and returned close to the baseline level within 30 s (Figures 3, 4A, 4C and 4E). 216 
Interestingly, in the subacute phase (i.e. 1-5 min after CAO) the CoBF reduction was less 217 
than 10% in all three cortical regions without any significant inter-regional difference (Figure 218 
5B). One can conclude from these observations that the existing macrovascular connections 219 
(i.e. the circle of Willis) are not sufficient to immediately and completely compensate for the 220 
loss of one carotid artery, and active vasodilation is required to accommodate cerebrocortical 221 
circulation to the altered hemodynamic situation. In addition, the observation that CAO 222 
resulted in a significant CoBF reduction of the frontoparietal region as compared to the 223 
contralateral hemisphere in spite of the common blood supply of these brain areas by the 224 
AACA indicates redistribution of the CoBF via pial collaterals to the severely ischemic 225 
temporal cortex on the side of CAO. 226 
Effects of CAO on the regional CoBF in eNOS-KO mice  227 
Our observations in WT mice indicated that the adaptation of cerebrocortical circulation to 228 
unilateral CAO involves pial and/or microvascular vasodilation. Since endothelial NO is a 229 
major regulator of the microvascular resistance in cerebral circulation (12, 13) we tested the 230 
hypothesis that eNOS may play a significant role in the adaptation to CAO. Changes of the 231 
regional CoBF after CAO in eNOS-KO animals, however, resembled in many ways the 232 
findings in WT mice (Figure 4B, 4D, 4F). The temporal pattern showed an acute drop 233 
followed by gradual recovery in all three cerebrocortical regions under investigation. In 234 
addition, similarly to WT animals, the acute reduction was most pronounced in the temporal 235 
cortex (Figure 5A), whereas during the subacute phase this inter-regional difference 236 
disappeared (Figure 5B). Surprisingly, the percentual changes of the regional CoBF showed 237 
no significant difference between eNOS-KO and WT mice either during the acute (Figure 238 
5A) or the subacute (Figure 5B) phase after CAO. In fact, the recovery even appeared to be 239 
more rapid in the temporal cortex of eNOS KO mice as compared to WT controls (Figures 240 
4E and 4F). 241 
 242 
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Discussion 243 
The present study was designed to investigate the cerebrovascular compensatory mechanisms 244 
developing after unilateral occlusion of the CCA. We aimed to answer three basic questions: 245 
Does the adaptation of cerebral circulation to the altered hemodynamic state after CAO 246 
involve flow changes and active vasodilation in the large arteries of the Willis circle? Do 247 
small pial collateral arteries between territories of the main cerebrocortical arteries (AACA 248 
and MCA) contribute to the redistribution of the CoBF? Is eNOS involved in the 249 
cerebrovascular adaptation to CAO? 250 
In our experiments CoBF was reduced rapidly and simultaneously in the ipsilateral frontal, 251 
parietal and temporal cerebrocortical regions after CAO (Figure 4.). However, after the acute 252 
phase, CoBF started to increase in the affected regions and returned close to the baseline 253 
level within 30 s, and 1-5 min after CAO the reduction of CoBF was less than 10% in all 254 
three cortical regions without any significant inter-regional differences. Similar dynamics of 255 
initial CoBF changes have been reported in the parietal cortex of anesthetized rats (35), 256 
followed by an overshoot of the blood flow, which was absent in our present study. One can 257 
conclude from these observations that the existing macrovascular connections (i.e. the 258 
arteries of the Willis circle) are not sufficient to compensate immediately and completely for 259 
the loss of one CCA, and that active cerebral vasodilation is required to adapt cerebrocortical 260 
circulation to the altered hemodynamic situation.  261 
In our present study unilateral closure of the CCA resulted in instant, significant CoBF 262 
reduction in the temporal cortex of the ipsilateral hemisphere. This was expected, since this 263 
region is supplied by the MCA originating from the circle of Willis close to the influx of the 264 
internal carotid artery. However, it was unexpected that the ipsilateral frontal and parietal 265 
cortices also showed reduced blood perfusion as compared to the contralateral ones, although 266 
in mice all of these brain regions receive their blood supply from the same artery, namely the 267 
AACA. This observation can only be explained by a draining effect through connections 268 
between the territories of the MCA and AACA, via pial anastomoses. The presence of such 269 
connections (16, 28, 29, 52), as well as their importance after MCA occlusion (50, 56) have 270 
already been demonstrated. However, to the best of our knowledge, the present study is the 271 
first indication for the involvement of small pial anastomoses in the acute adaptation of 272 
cerebrocortical circulation to CCA occlusion. We assume that a steal phenomenon may 273 
develop, and the blood flow of pial arteries supplying the fronto-parietal regions is drained 274 
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via pial anastomic vessels to the more ischemic temporal cortex of the hemisphere ipsilateral 275 
to the CCA occlusion. Interestingly, 15 days after CAO, markedly enlarged pial anastomic 276 
connections have been reported in mice indicating the significant contribution of these 277 
collateral vessels also to the chronic adaptation of the cerebrocortical circulation to CAO (16)  278 
and similar results have been obtained 6 days after MCA occlusion in mice (56). 279 
It is an important question whether the simple existence of collaterals is sufficient for the 280 
normalization of cerebrocortical circulation after CAO, or their active dilation is also required 281 
for the compensation. To answer this question, the distribution of cerebrovascular resistance 282 
along the arterial vessel tree has to be considered. Table 2 gives an overview of the 283 
experimental data available. It can be concluded that large cerebral vessels, including the 284 
circle of Willis, significantly contribute to the total cerebrovascular resistance, since in 285 
normotensive animals the blood pressure in the first order branches of the MCA is 39-54% 286 
lower than the systemic mean arterial pressure. The contribution of pial vessels, however, is 287 
also significant, evidenced by the additional 10-32% pressure drop from the first order MCA 288 
branches to the penetrating arteries/arterioles. These data indicate that vasodilation both in 289 
the circle of Willis and pial arteries could improve the blood perfusion of the MCA territory 290 
after CAO. The observations that during changes in systemic blood pressure small pial 291 
vessels as well as large cerebral arteries simultaneously contribute to the CoBF 292 
autoregulation by changing their diameter/resistance (17, 18, 44) suggest that adaptation of 293 
the cerebrocortical circulation to CAO may also involve an active vasodilation both in the 294 
small and the large cerebral arteries. The temporal pattern of the recovery of CoBF after 295 
CAO in our present study also indicates that vasodilation has to develop in order to achieve 296 
the optimal level of adaptive responses in the cerebrovascular system. 297 
An additional mechanism, which can aid the normalization of the brain’s regional blood 298 
perfusion after CAO, is the reduction of the resistance in intraparenchymal microvessels. 299 
These changes can be governed by different regulatory pathways, including myogenic, 300 
metabolic, neurogenic and endothelial mechanisms. Reduction of the myogenic tone as a 301 
response to the smaller transmural pressure, (i.e. weaker wall tension due to the reduced 302 
intraluminar pressure), enhanced release of vasodilatory neurotransmitters from the neurons 303 
and nerve endings and accumulation of metabolic end-products as a result of insufficient 304 
tissue blood perfusion are certainly among the regulatory factors. Several lines of evidence, 305 
however, indicate that vasoactive substances - especially NO - released from the 306 
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microvascular endothelium in response to the reduction of cerebral blood supply are crucially 307 
important contributors to the maintenance of cerebral blood flow. 308 
NO has been shown to play a major, complex role in the regulation of cerebral circulation. A 309 
multitude of in vitro as well as in vivo studies support that it contributes significantly to the 310 
control of the resting cerebral vascular tone, it has a potent cerebral vasodilatory effect by 311 
mediating endothelium-dependent vascular relaxation, it acts directly on vascular smooth 312 
muscle, and plays a significant role in the mediation of CO2-induced as well as hypoxia-313 
induced cerebral vasodilation. It is well documented that following its release by the 314 
endothelium, NO diffuses into the vascular smooth muscle cells, where, by activating soluble 315 
guanylyl cyclase (sGC), it increases the intracellular concentration of cyclic guanine 316 
monophosphate (cGMP), which in turn eventually leads to smooth muscle relaxation and 317 
vasodilation (40). There is also evidence to suggest that NO causes vasodilation not only 318 
through cGMP-mediated mechanisms, but in certain species also by activating potassium 319 
channels (for review see (13)). 320 
In vitro studies, using large cerebral arteries provided most of the experimental evidence 321 
regarding endothelium-mediated cerebral vasodilation. It was proved that NO exerts a resting 322 
tonic vasodilatory effect on cerebral circulation, since the basal cGMP level was found to be 323 
significantly greater in cerebral arteries having intact endothelium, as compared to those from 324 
which the endothelium was removed (8, 24, 48). Cerebral vasodilation in response to 325 
acetylcholine and to other receptor-mediated agonists (such as serotonin, substance P and 326 
ADP), which activate eNOS by increasing intracellular calcium levels, was shown to be NO-327 
dependent (for review see (12)). 328 
In vivo studies (10) showed that topical application of the NOS inhibitor L-NMMA leads to 329 
constriction of the rat basilar artery, an effect that was reversed upon administration of the 330 
NO-precursor molecule L-arginine. In several species, under basal conditions, local and 331 
systemic application of NOS inhibitors was shown to provoke cerebral vasoconstriction and a 332 
decrease in CoBF (12). Due to the fact that systemic NOS inhibitors lead to an increase in the 333 
cerebral and the peripheral vascular resistance, it is logical to infer that resting levels of NO 334 
are necessary to maintain the resistance vessels in a relaxed state (22). In other studies, which 335 
tested mice and piglet pial arterioles, L-arginine administration was shown to dilate pial 336 
arterioles in a dose-dependent manner (7, 41).  337 
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NO was also shown to possess a basal inhibitory effect, which buffers spontaneous cerebral 338 
vasomotion (9), inhibits vasoconstriction in response to substances such as norepinephrine 339 
and serotonin (for review (12)), and thereby contributes to the maintenance of a stable CoBF. 340 
Studies have demonstrated that administration of non-selective NOS inhibitors leads to an 341 
enhancement of cerebral vascular oscillations (2, 9, 15, 21, 26), whereas NO caused an 342 
attenuation of vasomotion (22).  343 
Involvement of NO in the regulation of cerebral circulation during ischemia has also been 344 
extensively studied. An acute increase in NO concentration within minutes following 345 
ischemia has been observed (30), which, due to its rapidity, was attributed to an ischemia-346 
induced activation of the constitutive eNOS enzyme (57). Similar observations have also 347 
been made in a study, which utilized MCA occlusion to induce cerebral ischemia (23). The 348 
potentially beneficial consequence of an increase in NO during ischemia is the maintenance 349 
of CoBF through vasodilation and the inhibition of platelet and leukocyte aggregation (13). 350 
These effects, therefore, serve to limit the infarct’s size and reduce brain damage. The 351 
potential protective effect of endothelium-derived NO during and after cerebral ischemia has 352 
been pointed out by studies, which utilized eNOS-deficient mice (13). Administration of L-353 
arginine after MCA occlusion leads to the dilation of pial arterioles, to a reduction of infarct 354 
size and to an increase of CoBF (33, 34). On the other hand, NOS inhibitors were reported to 355 
induce either no effect or an increase in the ischemia-induced cerebral infarct size (for review 356 
see (12)). 357 
Based on the aforementioned literary data we hypothesized that endothelium-derived NO 358 
may play an important role in the cerebrovascular adaptation to CAO. According to our 359 
results, however, the CAO-induced acute ipsilateral CoBF reduction in the three investigated 360 
cerebrocortical regions of the eNOS-KO animals was not different from that of the control, 361 
wild-type mice, neither in the acute, nor in the subacute phase of the CAO. These results 362 
indicate that eNOS does not appear to play an important role in the CoBF redistribution after 363 
CAO. In fact, the faster recovery of CoBF in the temporal cortex of eNOS-KO compared to 364 
WT mice can be attributed to the elevated MABP in these animals. It has been previously 365 
described that systematically administered NOS inhibitors can increase arterial pressure in a 366 
dose-dependent manner and therefore enhance blood flow in collateral vessels, which supply 367 
cerebral regions that were rendered ischemic though arterial occlusion (32).  368 
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Limitations of our experimental approach have also to be considered during the interpretation 369 
of our findings. The fact, that eNOS-KO mice showed unaltered cerebrocortical adaptation 370 
following CAO-induced reduction of CoBF does not necessarily exclude the role of NO in 371 
these mechanisms. Several lines of evidence indicate that endothelium-dependent and -372 
independent vasodilator pathways may get activated in order to compensate for the absence 373 
of endothelial NO production and therefore the phenotypic consequences of the eNOS gene 374 
deletion may underestimate the importance of eNOS under physiological conditions. For 375 
instance, neuronal NOS (nNOS) may be upregulated in the absence of eNOS. It has been 376 
reported that eNOS- and nNOS-derived NO is simultaneously involved in a variety of 377 
cerebrovascular functions, including the regulation of resting cerebral blood flow (3), CO2-378 
mediated (38, 53) and neuronally induced vasodilation (6, 14) as well as flow-metabolism 379 
coupling (11, 13). Interestingly, it has been shown that nNOS within the brain is not only 380 
found in neurons, glial cells and perivascular nerves (12), but also in the endothelium of the 381 
cerebral vasculature (3). 382 
In conclusion, in the present study, taking advantage of the high temporal and spatial 383 
resolution of laser-speckle imaging, attempts were made to gain insight into the mechanisms 384 
of the adaptation of cerebrocortical microcirculation to unilateral occlusion of the common 385 
carotid artery. The transient reduction of the CoBF in all investigated regions of the 386 
ipsilateral hemisphere clearly indicate that, in spite of the well-developed macro- and 387 
microvascular collateral network and the robust myogenic control of the vascular tone, the 388 
feed-forward mechanisms of cerebrovascular regulation are not sufficient to prevent cerebral 389 
ischemia after CAO. The temporal pattern of the CoBF recovery after CAO suggests the 390 
significance of an active cerebrovascular vasodilator mechanism driven by metabolic, 391 
endothelial or neuronal signals. Surprisingly, eNOS-dependent vasodilation does not appear 392 
to be involved in this process. In contrast, intracortical redistribution of the CoBF, 393 
presumably via pial anastomoses between the MCA and AACA, appears to attenuate the 394 
ischemia of the most severely affected temporal cortex at the expense of reducing the blood 395 
perfusion of the frontoparietal regions.  396 
 397 
 398 
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Figure Legends 407 
 408 
Fig. 1. 409 
Localization of cerebrocortical regions on a representative laser-speckle image (panel A) and 410 
schematic illustration of their supplying vessels (panel B). Small arrows indicate pial 411 
anastomoses between the territories supplied by the middle cerebral arteries (MCA) and the 412 
azygos anterior cerebral artery (AACA). ICA, internal carotid artery; ACA, anterior cerebral 413 
artery; PCA, posterior cerebral artery; FP, frontal pole; B, bregma; λ, lambda 414 
 415 
Fig. 2. 416 
Mean arterial blood pressure (MABP) in WT (n=12) and eNOS-KO (n=11) mice (panel A) 417 
and its changes after left carotid artery occlusion (CAO) (panel B). CAO was performed at 418 
time point „0 s”. MABP was significantly higher in eNOS-KO animals at all time points, 419 
whereas ΔMABP differed from 210 s (*P<0.05, **P<0.01, ***P<0.001 between WT and 420 
eNOS-KO with 2-way ANOVA and Bonferroni’s post hoc test). Note the enhanced time 421 
resolution between (panel A) or before (panel B) the dashed lines. 422 
 423 
Fig. 3. 424 
Regional changes of the cerebrocortical blood flow (CoBF) at different time points after left 425 
carotid artery occlusion (CAO), shown as differerence images compared to the baseline 426 
CoBF, i.e. the averaged CoBF in 1 min preceding CAO. CAO was performed at time point 427 
„0”. AU, arbitrary units; F, P and T indicate the frontal, parietal and temporal regions, 428 
respectively according to the coordinates described on Fig. 1A. 429 
 430 
Fig. 4. 431 
Regional cerebrocortical blood flow (CoBF) in WT (n=12, panels A, C and E) and eNOS-KO 432 
(n=11, panels B, D and F) before and after carotid artery occlusion (CAO). CoBF is 433 
expressed as percentage of the baseline, i.e. the averaged values in 1 min preceding CAO. 434 
Blue and red symbols represent CoBF in the ipsilateral and contralateral hemispheres, 435 
respectively. (*P<0.05, **P<0.01, ***P<0.001 vs. „Contralateral” with 2-way ANOVA and 436 
Bonferroni’s post  hoc test). Note the enhanced time resolution between the dashed lines. 437 
 438 
 439 
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Fig. 5. 440 
Acute (panel A) and subacute (panel B) reductions of the regional cerebrocortical blood flow 441 
(CoBF) in the ipsilateral hemisphere of WT (filled bars, n=12) and eNOS-KO (open bars, 442 
n=11) mice after left carotid artery occlusion (CAO). CoBF values have been determined at 443 
their minimum („Acute”) or at 5 min after CAO („Subacute”), and reductions were expressed 444 
as percentage of the baseline, i.e. the average CoBF in 1 min preceding CAO. (*P<0.05, 445 
**P<0.01 vs. „Frontal”; #P<0.05, ##P<0.01 vs. „Parietal” with 2-way ANOVA and 446 
Bonferroni’s post hoc test.) 447 
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Tables 449 
  Table 1. Arterial blood gas and acid-base parameters in the   450 
  experimental groups 451 
Variable WT (n=12) eNOS-KO (n=11) 
PaO2 (mmHg) 113.5 ± 5.1 112.6 ± 5.1 
O2-Saturation (%) 97.5 ± 0.4 97.7 ± 0.3 
PaCO2 (mmHg) 41.2 ± 2.1 37.6 ± 2.5 
pH 7.30 ± 0.02 7.32 ± 0.02 
SBE (mmol/l) -6.0 ± 1.0 -6.4 ± 0.7 
[HCO3-] (mmol/l) 19.7 ± 0.9 18.7 ± 0.6 
Hematocrit (%) 38.4 ± 1.0 39.4 ± 1.2 
 452 
 453 
 454 
Table 2. Blood pressure levels in different segments of the MCA expressed as 455 
percentage of the systemic MABP 456 
Species Anesthesia 
Systemic
MABP 
(mmHg)
Blood Pressure (% of MABP) in 
Reference 1st 2nd 3rd 4th* 
Order Branch of the MCA 
Rat Inactin 122 46% 43% 22% Harper et al. (17, 18) 
Cat Pentobarbital 70-140 61% 57% 55% 51% Shapiro et al. (44) 
Cat Pentobarbital 120  74%**  42%** Kontos et al. (25) 
Cat 
Ketamine + 
Halothane + 
N2O 
87   47%  
Schmidt-
Kastner et al. 
(42) 
Cat 
Chloralose + 
Urothane + 
Pancuronium 
115-117    60-63% Yamaguchi et al. (54) 
The level of pressure drop indicates the segmental distribution of cerebrovascular resistance. 457 
*Penetrating arterioles 458 
**Recalculated from resistance values 459 
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